IVERMECTIN 1% / METRONIDAZOLE 1%
X Sincerus Florida. LLC adverse reactions p Active. Inactive h NDC 72934-1130-2 IVERMECTIN USP 1% / METRONIDAZOLE USP 1% gel 30 gm c.
Medications with Generic Name Beginning ‘I’, Page 145
IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%
R Sincerus Florida. LLC adverse reactions x Active. Inactive. 123 NDC 72934-1131-2 IVERMECTIN USP 1% / METRONIDAZOLE USP 1% / NIACINAMIDE USP 4%. Gel 30gm x.
Tibsovo (Ivosidenib)
TIBSOVO is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test…
TIBSOVO (Ivosidenib)
TIBSOVO is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of adult patients with a susceptible IDH1 mutation as detected by an FDA-approved test with: Acute…
IXEMPRA (Ixabepilone)
IXEMPRA is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a…